vimarsana.com

Page 3 - Machine Learning Driven News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ODDITY Appoints Gil Efrati as CEO of SpoiledChild

ODDITY Appoints Gil Efrati as CEO of SpoiledChild
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Tel avivUnited statesNew yorkOran holtzmanNew york cityMachine learning driven

Breaking Tech Stock News: GBT (OTCPK: GTCH) Integrated Circuit s Geometrical Design Rule Automatic Correction Patent, Received a Notice of Allowance

Breaking Tech Stock News: GBT (OTCPK: GTCH) Integrated Circuit s Geometrical Design Rule Automatic Correction Patent, Received a Notice of Allowance

Danny rittmanExchange commissionTechnologies incTechnology platformsDesign rule checkReliability verificationArtificial intelligenceMachine learning drivenEnabled mobile technology platformsNews alertsDrone stocksGbt tokenizeOtc pinkIntegrated circuitEometrical design ruleUtomatic correction patent

ODDITY Invests $100M to Bring Pharma s AI Based Molecule Discovery Technology to Beauty and Wellness

With the acquisition of Boston-based Revela, a leading biotech startup, and the establishment of ODDITY LABS, the company is at the vanguard, bringing a proven drug discovery technology into beauty

Tel avivNew yorkUnited statesHarvard universityMassachusetts institute of technologyOran holtzmanConnor coleyRobertp pinkasEvan zhaoDavid mooneyYing tung evelyn chenAvinash boppanaRavi boppanaDavid zhangMichael braunHenri slezynger

Saama Collaborates with Merck to Build Machine Learning-Powered Clinical Data Layer to Strengthen Merck s Clinical Development Capabilities

BioPharma

United statesVivek sharmaEliav barrSuresh kattaMerck research laboratoriesHead of global clinical developmentSaama technologiesLife science analytics cloudMachine learningChairman emeritusSenior vice presidentGlobal clinical developmentChief medical officerMerck researchMachine learning driven

Saama Collaborates with Merck to Build Machine Learning-Powered Clinical Data Layer to Strengthen Mercks Clinical Development Capabilities

CAMPBELL, CA – (August 10, 2022) – Saama Technologies, LLC.

United statesVivek sharmaEliav barrSuresh kattaMerck research laboratoriesHead of global clinical developmentSaama technologiesLife science analytics cloudMachine learningChairman emeritusSenior vice presidentGlobal clinical developmentChief medical officerMerck researchMachine learning drivenNew drug applications

vimarsana © 2020. All Rights Reserved.